NASDAQ: PFXPhenixfin Corp Stock
$50.18-0.91 (-1.78%)
Updated Apr 17, 2025
PFX Price
$50.18
Fair Value Price
N/A
Market Cap
$101.35M
52 Week Low
$42.50
52 Week High
$57.40
P/E
6.16x
P/B
0.62x
P/S
4.51x
PEG
N/A
Dividend Yield
2.61%
Revenue
$22.68M
Earnings
$16.55M
Gross Margin
100%
Operating Margin
102.64%
Profit Margin
73%
Debt to Equity
0.92
Operating Cash Flow
-$57M
Beta
0.21
Next Earnings
May 8, 2025
Ex-Dividend
N/A
Next Dividend
N/A
PFX Overview
PhenixFIN Corporation is a business development company. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. Formerly Medley Capital Corp., PhenixFIN was founded in 2010 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PFX's potential to beat the market
- PFX doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Asset Management
Industry Rating
C
PFX
RankedUnranked of 85
RankedUnranked of 85
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $26.63 | B | |
| $14.78 | B | |
| $23.49 | B |
Be the first to know about important PFX news, forecast changes, insider trades & much more!
PFX News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PFX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PFX is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PFX is good value based on its earnings relative to its share price (6.16x), compared to the US market average (27.98x)
P/E vs Market Valuation
PFX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PFX due diligence checks available for Premium users.
Valuation
PFX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
6.16x
Industry
33.17x
Market
27.98x
PFX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PFX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PFX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.62x
Industry
2.52x
PFX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PFX's financial health
Profit margin
Revenue
$6.2M
Net Income
$2.5M
Profit Margin
39.6%
PFX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$311.9M
Liabilities
$149.2M
Debt to equity
0.92
PFX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PFX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$66.3M
Investing
$0.0
Financing
$5.9M
PFX vs Asset Management Stocks
Phenixfin Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.